113 related articles for article (PubMed ID: 19544363)
1. Characteristics and prognosis for molecular breast cancer subtypes in Chinese women.
Zhao J; Liu H; Wang M; Gu L; Guo X; Gu F; Fu L
J Surg Oncol; 2009 Aug; 100(2):89-94. PubMed ID: 19544363
[TBL] [Abstract][Full Text] [Related]
2. [Clinical characteristics and survival in the operable breast cancer patients with different molecular subtypes].
Zhang HM; Zhang BN; Xuan LX; Zhao P
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):447-51. PubMed ID: 19950556
[TBL] [Abstract][Full Text] [Related]
3. Characterization of breast cancer subtypes by quantitative assessment of biological parameters: relationship with clinicopathological characteristics, biological features and prognosis.
Del Casar JM; Martín A; García C; Corte MD; Alvarez A; Junquera S; González LO; Bongera M; García-Muñiz JL; Allende MT; Vizoso F
Eur J Obstet Gynecol Reprod Biol; 2008 Dec; 141(2):147-52. PubMed ID: 18768247
[TBL] [Abstract][Full Text] [Related]
4. Distribution of molecular breast cancer subtypes among Tunisian women and correlation with histopathological parameters: a study of 194 patients.
Ben Abdelkrim S; Trabelsi A; Missaoui N; Beizig N; Bdioui A; Anjorin A; Jomaa W; Mokni M
Pathol Res Pract; 2010 Nov; 206(11):772-5. PubMed ID: 20850937
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of basal-like subtype in triple-negative breast cancer.
Yamamoto Y; Ibusuki M; Nakano M; Kawasoe T; Hiki R; Iwase H
Breast Cancer; 2009; 16(4):260-7. PubMed ID: 19701681
[TBL] [Abstract][Full Text] [Related]
6. Presenting features of breast cancer differ by molecular subtype.
Wiechmann L; Sampson M; Stempel M; Jacks LM; Patil SM; King T; Morrow M
Ann Surg Oncol; 2009 Oct; 16(10):2705-10. PubMed ID: 19593632
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic features and five years survival analysis in molecular subtypes of breast cancer.
Zaha DC; Lazăr E; Lăzureanu C
Rom J Morphol Embryol; 2010; 51(1):85-9. PubMed ID: 20191125
[TBL] [Abstract][Full Text] [Related]
8. Frequency of HER-2/neu receptor positivity and its association with other features of breast cancer.
Naeem M; Nasir A; Aman Z; Ahmad T; Samad A
J Ayub Med Coll Abbottabad; 2008; 20(3):23-6. PubMed ID: 19610508
[TBL] [Abstract][Full Text] [Related]
9. [A study on the relationship between breast cancer molecular classification and prognosis].
Chen XS; Ma CD; Chen CM
Zhonghua Wai Ke Za Zhi; 2008 Sep; 46(18):1400-3. PubMed ID: 19094512
[TBL] [Abstract][Full Text] [Related]
10. Application of a new classification to a breast tumor series from a population-based cancer registry: demographic, clinical, and prognostic features of incident cases, Palermo Province, 2002-2004 .
Zarcone M; Amodio R; Campisi I; Cusimano R; Dolcemascolo C; Miceli V; Traina A; Macaluso M
Ann N Y Acad Sci; 2009 Feb; 1155():222-6. PubMed ID: 19250207
[TBL] [Abstract][Full Text] [Related]
11. Time to disease recurrence in basal-type breast cancers: effects of tumor size and lymph node status.
Dent R; Hanna WM; Trudeau M; Rawlinson E; Sun P; Narod SA
Cancer; 2009 Nov; 115(21):4917-23. PubMed ID: 19691094
[TBL] [Abstract][Full Text] [Related]
12. Molecular subtypes of breast cancers detected in mammography screening and outside of screening.
Sihto H; Lundin J; Lehtimäki T; Sarlomo-Rikala M; Bützow R; Holli K; Sailas L; Kataja V; Lundin M; Turpeenniemi-Hujanen T; Isola J; Heikkilä P; Joensuu H
Clin Cancer Res; 2008 Jul; 14(13):4103-10. PubMed ID: 18593987
[TBL] [Abstract][Full Text] [Related]
13. Gene-expression analysis and the basal-like breast cancer subtype.
Finnegan TJ; Carey LA
Future Oncol; 2007 Feb; 3(1):55-63. PubMed ID: 17280502
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer molecular subtypes in patients with locally advanced disease: impact on prognosis, patterns of recurrence, and response to therapy.
Huber KE; Carey LA; Wazer DE
Semin Radiat Oncol; 2009 Oct; 19(4):204-10. PubMed ID: 19732684
[TBL] [Abstract][Full Text] [Related]
15. Morphological characteristics of basal-like subtype of breast carcinoma with special reference to cytopathological features.
Ishihara A; Tsuda H; Kitagawa K; Yoneda M; Shiraishi T
Breast Cancer; 2009; 16(3):179-85. PubMed ID: 19466513
[TBL] [Abstract][Full Text] [Related]
16. [Clinicopathological characteristics and prognosis of patients with breast cancer over 65 years of age].
Gao JD; Zhang BN; Wang X; Wang J; Bi XF
Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(2):83-6. PubMed ID: 19489267
[TBL] [Abstract][Full Text] [Related]
17. Her-2/neu gene overexpression in breast carcinoma and its association with clinicopathological characteristics of the disease.
Ahmad A; Bano U; Gondal M; Khan A
J Coll Physicians Surg Pak; 2009 May; 19(5):297-9. PubMed ID: 19409162
[TBL] [Abstract][Full Text] [Related]
18. A significant proportion of elderly patients develop hormone-dependant "luminal-B" tumours associated with aggressive characteristics.
Durbecq V; Ameye L; Veys I; Paesmans M; Desmedt C; Sirtaine N; Sotiriou C; Bernard-Marty C; Nogaret JM; Piccart M; Larsimont D
Crit Rev Oncol Hematol; 2008 Jul; 67(1):80-92. PubMed ID: 18313937
[TBL] [Abstract][Full Text] [Related]
19. Molecular classifications of breast carcinoma with similar terminology and different definitions: are they the same?
Tang P; Wang J; Bourne P
Hum Pathol; 2008 Apr; 39(4):506-13. PubMed ID: 18289638
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological characteristics of triple-negative breast cancers.
Sasaki Y; Tsuda H
Breast Cancer; 2009; 16(4):254-9. PubMed ID: 19657711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]